US Treasury officials plan to discuss artificial intelligence and rare earths with China ahead of a Trump-Xi summit, according to reports dated September 18, 2026. Here is what these headlines actually say, what remains unknown, and the specific things a holder of rare earth, AI, or pharma names can check in their own portfolio right now.
What actually happened on September 18, 2026?
On September 18, 2026, three independent newsrooms reported a cluster of US-China developments centered on artificial intelligence and rare earths ahead of a planned Trump-Xi summit. According to Investing.com, US Treasury Secretary Bessent plans to discuss AI and rare earths with China's He, citing a source.
The reporting is hours old and several details are not yet confirmed. Here is what the headlines support, stated plainly:
- Bessent plans talks with China's He on AI and rare earths, per a source cited by Investing.com.
- The US and China are positioning on AI leadership before a Trump-Xi summit, per Bloomberg.
- An AI error nearly sparked a US-China military collision in the Middle East, per CNN via Investing.com.
- The US is weighing allowing most pharma licensing deals with China, per Investing.com sources.
- China Rare Earth Group is in talks to buy MP Materials shareholder Shenghe Resources, per Reuters via Seeking Alpha.
That is the full factual footprint. Anything beyond it, including timing, terms, or market reaction, is not established by these sources.
Which parts are confirmed and which are still unknown?
Most of these items are described as plans, talks, or things being weighed, not done deals. That distinction matters for how you read them.
What is reported
- Bessent intends to raise AI and rare earths with He, per a single cited source.
- A Trump-Xi summit is referenced as upcoming, though the reporting here does not fix a date.
- China Rare Earth Group is in talks regarding Shenghe Resources, a shareholder in MP Materials (MP).
What is not yet known
- Whether any talks produce an agreement, and on what terms.
- Whether the pharma licensing change is adopted, and which deal categories it would cover.
- What the Shenghe transaction, if completed, would mean for MP Materials ownership or operations.
Honest uncertainty is the correct posture here. When a story is built on sources and plans, the responsible move is to track it, not to trade a headline as if it were a signed outcome. Our write-up on AI slowdown fears and what to check walks through the same discipline for a different AI-linked story.
Why do these headlines matter for retail portfolios?
They matter because rare earths, AI hardware, and China-linked pharma sit inside a lot of ordinary portfolios, often without the holder noticing. Broad index funds, sector ETFs, and popular single names carry this exposure indirectly.
The names and themes most directly referenced by these reports include:
- MP Materials (MP), named directly through the Shenghe stake reporting.
- Rare earth and critical mineral miners and processors more broadly.
- AI hardware and semiconductor names, given the AI-leadership framing.
- Pharmaceutical companies with China licensing pipelines, if the licensing change advances.
None of that is a reason to act blindly. It is a reason to know precisely what you own, which is a different and calmer task.
How can a PortfolioTrackr user check their exposure right now?
Start by finding out whether you actually hold any of the names or sectors in these headlines, because most people are less exposed, or more exposed, than they assume. PortfolioTrackr lets you group holdings by sector and by geography so you can see rare earth, semiconductor, and pharma weightings in one view.
A practical sequence for today:
- Search your holdings for MP and any rare earth or critical mineral ETF you may own.
- Group by sector to see your combined AI hardware and semiconductor weight, including exposure hiding inside broad funds.
- Check geography for China-linked revenue in your pharma and tech positions.
- Review concentration so you know, in plain numbers, how much of your portfolio a single theme represents.
If you have not connected accounts, connecting is optional. Manual entry, CSV import, broker screenshots, voice, and text all work on every plan, so you can build an accurate picture even without linking a broker. Our guide on connecting a brokerage account covers the linked route for those who want it.
How do price alerts help on a developing story like this?
Price alerts let you decide your own levels in advance and get told when a name reaches them, so you are not glued to a screen while a multi-day diplomatic story unfolds. PortfolioTrackr checks every position and every watchlist level once a minute, around the clock, and you hear within a minute of your level being hit.
How that works in practice:
- Set a level on MP or on a rare earth ETF and you get alerted within a minute of it being reached.
- PortfolioTrackr reports status against your own levels, such as still below target, Target 1 reached, or stop-loss level reached. It does not tell you what to do.
- Watchlist alerts let you monitor names you do not yet own, such as a China pharma licensor, on Pro and Lifetime plans.
- A recurring alert repeats for the same target at most once every five minutes, so you are not buried in noise.
Setting an alert is not a decision to trade. It is a way to be informed on your own terms.
How does this compare with other recent geopolitical shocks?
Compared with sharp single-commodity events, this is a slower, policy-driven story with several separate threads, which changes how you monitor it. A supply shock hits a price fast; a diplomatic track plays out over days and headlines.
| Event type | Speed | Main exposure to check |
|---|---|---|
| US-China AI and rare earth talks | Days, multi-thread | Rare earths, AI hardware, China pharma |
| Oil supply shock | Hours | Energy, airlines, transport |
| Inflation print | Same day | Rate-sensitive growth, bonds |
For a live example of the fast kind, see our breakdown of how an oil spike moves stocks and airlines. For the slower policy variety, the UK inflation explainer shows how to read a data-driven event without overreacting.
What should investors watch next?
Watch for confirmation, because right now most of these items are plans and talks rather than completed actions. The concrete markers to track over the coming days:
- Whether a Trump-Xi summit date is formally set.
- Any readout from Bessent-He discussions on AI and rare earths.
- Whether the pharma licensing change is adopted and which deals it covers.
- Progress on the China Rare Earth Group and Shenghe Resources talks, and any statement referencing MP Materials.
- The follow-up on the reported AI-related military near-miss, which speaks to the wider tension backdrop.
You can keep the relevant tickers on a PortfolioTrackr watchlist and let alerts surface movement, rather than refreshing news feeds all day.
The bottom line
As of September 18, 2026, the reporting points to planned US-China talks on AI and rare earths, a possible easing on pharma licensing, and a potential ownership change touching MP Materials through Shenghe Resources. These are early-stage items, and the terms and outcomes are not yet known.
The steady response is to check what you own, set your own alert levels, and watch the confirmation points above. Knowing your exposure is not the same as acting on it, and on a story this young, clarity beats speed.
Find out what you are actually exposed to
Sector and currency concentration across every account you hold, benchmarked against the S&P 500, NASDAQ and gold.
Check My Exposure
Frequently asked questions
What did the US-China rare earth and AI headlines say on September 18?
On September 18, 2026, reports said US Treasury Secretary Bessent plans to discuss AI and rare earths with China's He ahead of a Trump-Xi summit, that the US is weighing allowing most pharma licensing deals with China, and that China Rare Earth Group is in talks to buy MP Materials shareholder Shenghe Resources.
Is MP Materials being acquired by a Chinese company?
No. Reuters reporting says China Rare Earth Group is in talks to buy Shenghe Resources, which is a shareholder in MP Materials, not MP Materials itself. The talks are not confirmed as completed, and what they would mean for MP's ownership or operations is not yet known.
How can I see if my portfolio has rare earth or AI exposure?
PortfolioTrackr lets you group holdings by sector and geography, so you can see combined rare earth, semiconductor, and China-linked pharma weightings in one view. This surfaces exposure hidden inside broad index funds and ETFs. Manual entry, CSV, and screenshots work on every plan if you prefer not to link a broker.
Should I sell rare earth or AI stocks after this news?
This article does not give buy or sell advice. The reported items are early-stage plans and talks, with terms and outcomes still unknown. A reasonable step is to check your own exposure, review your concentration, and set alert levels you choose in advance so you are informed if prices move.
How fast do PortfolioTrackr price alerts notify me?
PortfolioTrackr checks every position and watchlist level once a minute, around the clock, and you hear within a minute of your level being hit. It reports status against your own targets, such as Target 1 reached or stop-loss level reached, without telling you what to do. Watchlist alerts are a Pro and Lifetime feature.